Bisphosphonate-Related Osteonecrosis of the Mandible and Maxilla: Clinical and Imaging Features

被引:7
作者
Gill, Sonia B. [1 ]
Valencia, Maria P. [1 ]
Sabino, Mary Lou C. [1 ]
Heideman, Gregory M. [1 ]
Michel, Michelle A. [1 ]
机构
[1] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA
关键词
mandible; maxilla; jaws; osteonecrosis; bisphosphonates; MULTIPLE-MYELOMA; ZOLEDRONIC ACID; RISK-FACTORS; SKELETAL COMPLICATIONS; BREAST-CARCINOMA; DOUBLE-BLIND; JAW; BONE; METASTASES; PREVENTION;
D O I
10.1097/RCT.0b013e318186b179
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Bisphosphonate-related osteonecrosis of the jaws is a rare, but morbid, condition. We present the clinical and imaging features of 19 patients. Methods: A review of 19 bisphosphonate-related osteonecrosis patients was performed. Patient demographics, diagnosis, dental procedures, symptoms and clinical findings, location and pattern of involvement, and presence of fractures, sequestra, and fistulae were documented. Results: Patients included 14 women and 5 men aged 48 to 80 years. Diagnoses included breast carcinoma (n = 11), multiple myeloma (n = 4), osteoporosis (n = 4), prostate carcinoma (n = 2), and lymphoma (n = 1). Seventeen patients received intravenous and 2 received oral bisphosphonates for 2 to 5 years. Bone involvement was noted in the mandible (74%), maxilla (16%), and both (10%). A lytic and sclerotic pattern was most common (58%). Additional findings included fractures (n = 5), sequestra (n = 4), and oroantral fistulae (n = 2). Conclusions: Bisphosphonate-related osteonecrosis is a rare, but morbid, condition, and imaging features can mimic other conditions. It is important for the radiologist to consider this entity in the appropriate clinical setting.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 38 条
  • [2] Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors
    Badros, A
    Weikel, D
    Salama, A
    Goloubeva, O
    Schneider, A
    Rapoport, A
    Fenton, R
    Gahres, N
    Sausville, E
    Ord, R
    Meiller, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 945 - 952
  • [3] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
    Bamias, A
    Kastritis, E
    Bamia, C
    Moulopoulos, LA
    Melakopoulos, L
    Bozas, G
    Koutsoukou, V
    Gika, D
    Anagnostopoulos, A
    Papadimitriou, C
    Terpos, E
    Dimopoulos, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8580 - 8587
  • [4] Berenson J, 1996, BRIT J CLIN PRACT, P5
  • [5] Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO
  • [6] 2-0
  • [7] Carneiro E, 2006, AM J NEURORADIOL, V27, P1096
  • [8] Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws
    Chiandussi, S.
    Biasotto, M.
    Dore, F.
    Cavalli, F.
    Cova, M. A.
    Di Lenarda, R.
    [J]. DENTOMAXILLOFACIAL RADIOLOGY, 2006, 35 (04) : 236 - 243
  • [9] Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968
  • [10] A woman with a nonhealing ulcer of the jaw - Gingival ulceration, inflammation, and acute osteomyelitis with actinomyces, all associated with necrosis of bone (bisphosphonate-related osteonecrosis of bone)
    Dodson, Thomas B.
    Raje, Noopur S.
    Caruso, Paul A.
    Rosenberg, Andrew E.
    Smullin, Steven E.
    Harris, Nancy Lee
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12) : 1283 - 1291